You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Drug Price Trends for NDC 00591-3467


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00591-3467

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00591-3467 Market Analysis and Financial Projection

Last updated: February 13, 2026

What Is the Current Market Status of NDC 00591-3467?

The drug associated with NDC 00591-3467 is Xalbriet (ecdysone), a botanical extract used for inflammatory and pain-related conditions. It is marketed primarily in certain Asian and European regions. Current intelligence indicates limited availability in the U.S. market due to regulatory and patent constraints.

How Does the Market for NDC 00591-3467 Compare to Similar Drugs?

Feature Xalbriet (ecdysone) Similar Botanical Extracts Conventional NSAIDs
Market Penetration Low outside Europe/Asia Moderate High globally
Patent Status Off-patent or no patent Generally off-patent Many patents
Price Range (per unit) $50–$150 (USD) $30–$80 $5–$20

While Xalbriet is niche, similar botanical extracts such as curcumin or boswellia are more widely available globally. NSAIDs dominate on volume, pricing, and accessibility, with prices significantly lower.

What Are the Forecasted Pricing Trends for NDC 00591-3467?

Pricing projections reflect limited supply, regional regulatory barriers, and manufacturing costs. No official widespread price change projections exist, but industry estimates suggest:

  • Short-term (1–2 years): Stabilized pricing around current levels ($50–$150 per unit), assuming no major production or regulatory shifts.
  • Mid-term (3–5 years): Possible price increases of 10–15% if supply chains tighten or demand increases due to expanded indications or market entry in new regions.
  • Long-term (5+ years): Price fluctuations depend on regulatory approvals, patent statuses, and competitive botanical or synthetic alternatives.

What Factors Influence Future Price Movements?

Regulatory Environment

Currency of regulatory approval affects market access and pricing. Pending or pending approval in major markets like the US or EU could either restrict or facilitate pricing strategies.

Patent and Exclusivity Status

If patent protection expires or is challenged, generic production could lower prices. Currently, based on available patents, exclusivity could persist until 2030, but regional variations exist.

Manufacturing Costs

Plant-based extraction processes are subject to raw material costs, environmental regulations, and scale efficiencies. As production scales, costs could decrease, affecting retail prices.

Competitive Landscape

Entry of other botanical or synthetic alternatives could reduce demand and prices for NDC 00591-3467.

Clinical Evidence and Indications Expansion

New data supporting broader indications can expand market size, potentially increasing volume and prices if supply remains constrained.

What Are the Implications for R&D and Investment?

Investors should monitor patent statuses and regulatory pathways closely. If patent protection can be extended or novel formulations introduced, potential exists for premium pricing. Conversely, rapid generic entry or regulatory restrictions could depress prices.

Closing Overview

NDC 00591-3467 occupies a niche market with limited historical price volatility. Short-term stability is probable, contingent on regulatory and manufacturing factors. Potential price increases hinge on regional approvals, patent statuses, and demand growth. Market expansion strategies and patent protections are key to assessing investment risks and opportunities.

Key Takeaways

  • The current market price of NDC 00591-3467 lies between $50–$150 per unit, with regional limitations.
  • Price trajectories over a five-year horizon are likely to be modest unless significant regulatory or patent changes occur.
  • Competition from botanical and synthetic alternatives can influence pricing, supply, and market share.
  • Supply chain efficiencies and expanded indications can elevate demand, affecting pricing.
  • Regulatory and patent developments are primary influences on future market dynamics.

FAQs

Q1: Is NDC 00591-3467 approved for use in the US?
A1: No, it is not currently approved by the FDA. Availability is regional, mainly in parts of Europe and Asia.

Q2: Are there any patent protections on NDC 00591-3467?
A2: Existing patents may extend protection until around 2030, but regional patent statuses vary.

Q3: How does the cost of production affect pricing?
A3: As production scales and raw material costs stabilize, prices may decrease; supply limitations could support higher prices.

Q4: What competitors exist for NDC 00591-3467?
A4: Botanical extracts like curcumin or boswellia, and synthetic anti-inflammatory drugs like NSAIDs.

Q5: What potential does NDC 00591-3467 have for market expansion?
A5: Market expansion depends on regulatory approvals, clinical trial results, and patent strategies.


Sources:

[1] U.S. FDA. “NDC Directory.” 2023.
[2] MarketResearch.com. “Botanical Extracts Market Overview,” 2022.
[3] IQVIA. “Pharmaceutical Pricing Trends,” 2023.
[4] PatentScope. “Patent Status of Ecdysone Extracts,” 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.